TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 26 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2014. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,058,000 | -41.0% | 200,000 | 0.0% | 0.20% | +19.5% |
| Q2 2015 | $1,794,000 | +41.9% | 200,000 | 0.0% | 0.17% | +42.0% |
| Q1 2015 | $1,264,000 | +8.2% | 200,000 | 0.0% | 0.12% | +6.2% |
| Q4 2014 | $1,168,000 | -14.7% | 200,000 | 0.0% | 0.11% | -20.6% |
| Q3 2014 | $1,370,000 | -52.3% | 200,000 | 0.0% | 0.14% | -42.7% |
| Q2 2014 | $2,870,000 | +37.8% | 200,000 | 0.0% | 0.25% | +44.7% |
| Q1 2014 | $2,082,000 | – | 200,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 467,639 | $4,868,000 | 0.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $1,041,000 | 0.24% |
| DAFNA Capital Management LLC | 25,000 | $260,000 | 0.22% |
| BLUESTEIN R H & CO LLC | 286,100 | $2,978,000 | 0.20% |
| WALL STREET ASSOCIATES | 200,000 | $2,082,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 275,000 | $2,863,000 | 0.16% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 275,000 | $2,860,000 | 0.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 147,747 | $1,538,000 | 0.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 244,524 | $2,545,000 | 0.10% |
| Lombard Odier Asset Management (USA) Corp | 239,500 | $2,493,000 | 0.10% |